Têtu B - Search Results

1

Establishment and characterization of a new cell line derived from a human primary breast carcinoma.

Wang CS, Goulet F, Lavoie J, Drouin R, Auger F, Champetier S, Germain L, Têtu B. Wang CS, et al. Among authors: tetu b. Cancer Genet Cytogenet. 2000 Jul 1;120(1):58-72. doi: 10.1016/s0165-4608(99)00253-8. Cancer Genet Cytogenet. 2000. PMID: 10913678

2

Stromelysin-3 expression by mammary tumor-associated fibroblasts under in vitro breast cancer cell induction.

Wang CS, Têtu B. Wang CS, et al. Among authors: tetu b. Int J Cancer. 2002 Jun 20;99(6):792-9. doi: 10.1002/ijc.10430. Int J Cancer. 2002. PMID: 12115479

3

Selective culture of epithelial cells from primary breast carcinomas using irradiated 3T3 cells as feeder layer.

Wang CS, Goulet F, Tremblay N, Germain L, Auger F, Têtu B. Wang CS, et al. Among authors: tetu b. Pathol Res Pract. 2001;197(3):175-81. doi: 10.1078/0344-0338-00030. Pathol Res Pract. 2001. PMID: 11314781

4

Production of bioengineered cancer tissue constructs in vitro: epithelium-mesenchyme heterotypic interactions.

Wang CS, Goulet F, Auger F, Tremblay N, Germain L, Têtu B. Wang CS, et al. Among authors: tetu b. In Vitro Cell Dev Biol Anim. 2001 Jul-Aug;37(7):434-9. doi: 10.1290/1071-2690(2001)037<0434:POBCTC>2.0.CO;2. In Vitro Cell Dev Biol Anim. 2001. PMID: 11573818

5

Expression of cathepsin D, stromelysin-3, and urokinase by reactive stromal cells on breast carcinoma prognosis.

Têtu B, Brisson J, Wang CS, Lapointe H, Beaudry G, Blanchette C. Têtu B, et al. Cancer. 2001 Dec 1;92(11):2957-64. doi: 10.1002/1097-0142(20011201)92:11<2957::aid-cncr10112>3.0.co;2-6. Cancer. 2001. PMID: 11753972

6

mdr1 mRNA expression by RT-PCR in patients with primary breast cancer submitted to neoadjuvant therapy.

Wang CS, LaRue H, Fortin A, Gariépy G, Têtu B. Wang CS, et al. Among authors: tetu b. Breast Cancer Res Treat. 1997 Aug;45(1):63-74. doi: 10.1023/a:1005824704740. Breast Cancer Res Treat. 1997. PMID: 9285118 Clinical Trial.

7

Cathepsin D expression by cancer and stromal cells in breast cancer: an immunohistochemical study of 1348 cases.

Têtu B, Brisson J, Lapointe H, Wang CS, Bernard P, Blanchette C. Têtu B, et al. Breast Cancer Res Treat. 1999 May;55(2):137-47. doi: 10.1023/a:1006140213493. Breast Cancer Res Treat. 1999. PMID: 10481941

8

[Proteases by reactive stromal cells in cancer: an attractive therapeutic target].

Têtu B, Trudel D, Wang CS. Têtu B, et al. Bull Cancer. 2006 Sep;93(9):944-8. Bull Cancer. 2006. PMID: 16980237 Free article. Review. French.

9

The influence of MMP-14, TIMP-2 and MMP-2 expression on breast cancer prognosis.

Têtu B, Brisson J, Wang CS, Lapointe H, Beaudry G, Blanchette C, Trudel D. Têtu B, et al. Breast Cancer Res. 2006;8(3):R28. doi: 10.1186/bcr1503. Epub 2006 Jun 15. Breast Cancer Res. 2006. PMID: 16776850 Free PMC article.

10

Ovarian metastases of breast carcinoma. A clinicopathologic study of 59 cases.

Gagnon Y, Têtu B. Gagnon Y, et al. Among authors: tetu b. Cancer. 1989 Aug 15;64(4):892-8. doi: 10.1002/1097-0142(19890815)64:4<892::aid-cncr2820640422>3.0.co;2-c. Cancer. 1989. PMID: 2743281

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

242 results

Search Page

Filters